CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 50 enrolled
Drug / intervention
Angiographic run with new algorithm and low dose (50% dose) +1 moreradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01684826
NCT01684826N/ACompleted

Clinical Validation and Evaluation of ClarityIQ Cardiac Image Processing for Cardiac Angiography and Intervention

Philips Clinical & Medical Affairs Global·interventional·Posted Sep 13, 2012·Updated Mar 8, 2022

In Brief

A clinical study evaluating Angiographic run with new algorithm and low dose (50% dose) and Angiographic run with predecessor algorithm and dose (100%) for Vascular Diseases. Completed, enrolled 50 participants across 1 site.

Detailed Summary

ClarityIQ is a novel X-ray imaging technology, that combines advanced real-time image noise reduction algorithms, with state-of-the-art hardware to reduce patient entrance dose significantly. This is realized by anatomy-specific optimization of the full acquisition chain (grid switch, beam filtering, pulse width, spot size, detector and image processing engine) for every clinical task individually. Furthermore, smaller focal spot sizes and shorter pulses are used, which are known to positively influence image quality . The final effect on the clinical image quality is investigated in this study.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesNetherlands
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedSep 13, 2012
Enrollment StartSep 1, 2012
Primary CompletionNov 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 13.8 years ago

Interventions

Angiographic run with new algorithm and low dose (50% dose)radiation

Angiographic run with new algorithm and low dose (50% lower dose compared to Xper)

Angiographic run with predecessor algorithm and dose (100%)radiation

Angiographic run with predecessor algorithm and dose (100% dose)